Latest Breaking News On - Lejla vajzovic - Page 3 : comparemela.com

Ocugen (OCGN) Reports Positive Clinical Study Update from the Phase 1/2 Trial of OCU400

Ocugen (OCGN) Reports Positive Clinical Study Update from the Phase 1/2 Trial of OCU400
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesShankar musunuriLejla vajzovicTarun upadhyayDavid boyerHead of researchAboutocugen inc ocugenKeck school of medicine los angelesDuke university school of medicineOcugen incRetina foundation of theTiffany hamiltonhead of communicationsRetina vitreous associates medical groupRetinitis pigmentosaChief executive officer

Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)

Favorable safety and tolerability profile of OCU400 investigational drug product in RP and LCA subjects to dateClinical study update suggests continued positive trends in Best-Corrected Visual Acuity .

Los angelesUnited statesTarun upadhyayDavid boyerLejla vajzovicShankar musunuriRetina vitreous associates medical groupOcugen incRetina foundation of theDuke university school of medicineAboutocugen incKeck school of medicine los angelesHead of communicationsHead of researchBest corrected visual acuityMulti luminance mobility testing

Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier

FavorablesafetyandtolerabilityprofileofOCU400investigationaldrugproductin RP and LCA subjects to dateClinical study update suggests continued positive trends in Best-Corrected Visual Acuity (BCVA) and Multi-Luminance Mobility Testing (MLMT), as well as positive trends in Low-Luminance

Los angelesUnited statesTarun upadhyayLejla vajzovicDavid boyerShankar musunuriHead of researchOcugen incRetina vitreous associates medical groupHead of communicationsKeck school of medicine los angelesRetina foundation of theDuke university school of medicineBest corrected visual acuityMulti luminance mobility testingLow luminance visual acuity

Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGeorge lasezkayWilliamd humphriesRahuln khuranaThomasa ciullaRemy bernardaClayb thorpClearside asia pacificArshadm khananiLejla vajzovicJenny kobinClearside biomedical incAssociation for researchInternational organization for standardizationAmerican society of retina specialistsAlcami corporation

Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesClearside asia pacificJenny kobin remy bernardaClayb thorpRahuln khuranaWilliamd humphriesThomasa ciullaGeorge lasezkayLejla vajzovicArshadm khananiDevelopment rd expensesAssociation for researchExchange commissionClearside biomedical incAlcami corporationInternational organization for standardization